Financial results - LYRAFARM 2003 SRL

Financial Summary - Lyrafarm 2003 Srl
Unique identification code: 15669926
Registration number: J2003000547117
Nace: 4773
Sales - Ron
549.010
Net Profit - Ron
18.643
Employees
5
Open Account
Company Lyrafarm 2003 Srl with Fiscal Code 15669926 recorded a turnover of 2024 of 549.010, with a net profit of 18.643 and having an average number of employees of 5. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Lyrafarm 2003 Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 595.177 609.800 612.470 589.294 590.175 681.856 717.014 661.766 579.552 549.010
Total Income - EUR 630.165 644.599 641.131 619.029 617.945 711.248 741.365 706.494 628.801 572.988
Total Expenses - EUR 552.528 565.287 577.558 576.338 577.294 723.745 693.571 655.506 597.215 551.303
Gross Profit/Loss - EUR 77.637 79.312 63.574 42.691 40.651 -12.496 47.794 50.988 31.586 21.685
Net Profit/Loss - EUR 64.575 65.595 52.132 36.501 34.471 -19.117 40.380 43.945 25.335 18.643
Employees 4 5 4 3 4 4 5 5 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -4.7%, from 579.552 euro in the year 2023, to 549.010 euro in 2024. The Net Profit decreased by -6.551 euro, from 25.335 euro in 2023, to 18.643 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Lyrafarm 2003 Srl

Rating financiar

Financial Rating -
LYRAFARM 2003 SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Lyrafarm 2003 Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Lyrafarm 2003 Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Lyrafarm 2003 Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Lyrafarm 2003 Srl - CUI 15669926

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 46.085 44.249 60.465 49.742 43.175 33.632 22.196 10.901 1.503 0
Current Assets 55.944 60.795 52.789 64.383 73.677 85.775 70.935 76.765 91.953 77.562
Inventories 39.245 44.780 37.949 39.629 44.586 62.175 65.075 71.264 79.149 63.431
Receivables 371 20 8 8 3.711 208 0 0 3.765 3.751
Cash 16.328 15.994 14.832 24.747 25.380 23.391 5.859 5.501 9.039 10.380
Shareholders Funds 60.989 65.640 52.176 36.544 34.513 -19.076 21.749 43.985 25.376 18.683
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 41.041 39.404 61.079 77.581 82.339 138.482 71.382 43.681 68.081 58.879
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 77.562 euro in 2024 which includes Inventories of 63.431 euro, Receivables of 3.751 euro and cash availability of 10.380 euro.
The company's Equity was valued at 18.683 euro, while total Liabilities amounted to 58.879 euro. Equity decreased by -6.551 euro, from 25.376 euro in 2023, to 18.683 in 2024.

Risk Reports Prices

Reviews - Lyrafarm 2003 Srl

Comments - Lyrafarm 2003 Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.